Javascript must be enabled to continue!
IITR00803: a benzoxazole-nitrothiophene small molecule with broad-spectrum antibacterial potential
View through CrossRef
ABSTRACT
The drug discovery of novel antibacterials is pivotal to combat the ever-growing challenge of antibiotic resistance. The current antibiotics in clinics target the essential pathways in bacteria. However, drug efflux among other resistance mechanisms remains a persistent problem, leading to reduced efficacy of antibiotics. In the present study, we report the discovery of a novel small molecule, IITR00803, with antibacterial properties. IITR00803 demonstrated broad-spectrum antibacterial activity with potent inhibition of enteric pathogens. The small molecule contains a benzoxazole group and a nitrothiophene moiety in its chemical structure. The nitrothiophene-based compounds are prone to efflux by AcrAB-TolC efflux pumps. Despite containing the nitrothiophene group, IITR00803 did not demonstrate efflux liability, thereby demonstrating a broad antibacterial spectrum. The small molecule depicted bactericidal activity against
Salmonella enterica
serotype Typhimurium with a post-antibiotic effect of ~1.51 h. The mode of action studies revealed the membrane potential perturbing properties of IITR00803 against
S. enterica
serovar Typhimurium and
Escherichia coli,
whereas DNA-damaging activity was observed against
E. coli
. Resistance development studies on IITR00803 in laboratory growth media showed that
S. enterica
serovar Typhimurium could not develop stable resistance against this molecule under the tested conditions. Furthermore, IITR00803 exhibited non-toxic potential against eukaryotic cells and the model organism
Caenorhabditis elegans
. The compound also depicted efficacy against the
C. elegans
infection model of
S. enterica
serovar Typhimurium. Collectively, our results show that IITR00803 is a broad-spectrum antibacterial small molecule that alters membrane potential and exhibits
in vitro
and
in vivo
safety and efficacy.
IMPORTANCE
Antimicrobial resistance is a growing global health threat, necessitating the urgent development of novel antibacterial agents.
Salmonella
infections, particularly those originated by non-typhoidal serovars such as
Salmonella enterica
Typhimurium and
S. enterica
Enteritidis, contribute significantly to morbidity and mortality worldwide. These foodborne pathogens cause severe gastroenteritis and spread through poor sanitation and food safety measures, leading to millions of infections each year. The emergence of multidrug-resistant
Salmonella
strains has further complicated treatment by limiting the therapeutic options. This crisis highlights the need for the discovery of new therapeutic options that impede the resistance development of bacterial pathogens and demonstrate the potential to overcome existing antibiotic resistance mechanisms.
American Society for Microbiology
Title: IITR00803: a benzoxazole-nitrothiophene small molecule with broad-spectrum antibacterial potential
Description:
ABSTRACT
The drug discovery of novel antibacterials is pivotal to combat the ever-growing challenge of antibiotic resistance.
The current antibiotics in clinics target the essential pathways in bacteria.
However, drug efflux among other resistance mechanisms remains a persistent problem, leading to reduced efficacy of antibiotics.
In the present study, we report the discovery of a novel small molecule, IITR00803, with antibacterial properties.
IITR00803 demonstrated broad-spectrum antibacterial activity with potent inhibition of enteric pathogens.
The small molecule contains a benzoxazole group and a nitrothiophene moiety in its chemical structure.
The nitrothiophene-based compounds are prone to efflux by AcrAB-TolC efflux pumps.
Despite containing the nitrothiophene group, IITR00803 did not demonstrate efflux liability, thereby demonstrating a broad antibacterial spectrum.
The small molecule depicted bactericidal activity against
Salmonella enterica
serotype Typhimurium with a post-antibiotic effect of ~1.
51 h.
The mode of action studies revealed the membrane potential perturbing properties of IITR00803 against
S.
enterica
serovar Typhimurium and
Escherichia coli,
whereas DNA-damaging activity was observed against
E.
coli
.
Resistance development studies on IITR00803 in laboratory growth media showed that
S.
enterica
serovar Typhimurium could not develop stable resistance against this molecule under the tested conditions.
Furthermore, IITR00803 exhibited non-toxic potential against eukaryotic cells and the model organism
Caenorhabditis elegans
.
The compound also depicted efficacy against the
C.
elegans
infection model of
S.
enterica
serovar Typhimurium.
Collectively, our results show that IITR00803 is a broad-spectrum antibacterial small molecule that alters membrane potential and exhibits
in vitro
and
in vivo
safety and efficacy.
IMPORTANCE
Antimicrobial resistance is a growing global health threat, necessitating the urgent development of novel antibacterial agents.
Salmonella
infections, particularly those originated by non-typhoidal serovars such as
Salmonella enterica
Typhimurium and
S.
enterica
Enteritidis, contribute significantly to morbidity and mortality worldwide.
These foodborne pathogens cause severe gastroenteritis and spread through poor sanitation and food safety measures, leading to millions of infections each year.
The emergence of multidrug-resistant
Salmonella
strains has further complicated treatment by limiting the therapeutic options.
This crisis highlights the need for the discovery of new therapeutic options that impede the resistance development of bacterial pathogens and demonstrate the potential to overcome existing antibiotic resistance mechanisms.
Related Results
Effects of benzoxazol and its nitro-derivatives on growth indicators and chemical composition of tomato fruits
Effects of benzoxazol and its nitro-derivatives on growth indicators and chemical composition of tomato fruits
The present work is devoted to the study of the biological activity of benzoxazole, 5-nitrobenzoxazole and 5,7-dinitrobenzoxazole in relation to tomato plants. The ability of these...
Conformational Control of Substrate Selectivity in Benzoxazole-Forming Amidohydrolases
Conformational Control of Substrate Selectivity in Benzoxazole-Forming Amidohydrolases
Benzoxazoles are key heteroaromatic motifs found in pharmaceuticals, bioactive natural products, and synthetic lead structures. However, complex benzoxazole derivatives, such as bi...
Discovery and In Vitro Reconstitution of Closoxazole Biosynthesis from
Pyxidicoccus fallax
Discovery and In Vitro Reconstitution of Closoxazole Biosynthesis from
Pyxidicoccus fallax
Benzoxazoles are important structural components of both bioactive natural products and pharmaceutical active ingredients. In this study, a putative benzoxazole gene cluster origin...
Deep learning-enhanced single-molecule spectrum imaging
Deep learning-enhanced single-molecule spectrum imaging
Fluorescence is widely used in biological imaging and biosensing. Rich information can be revealed from the fluorescence spectrum of fluorescent molecules, such as pH, viscosity an...
Investigating the Antibacterial Characteristics of Japanese Bamboo
Investigating the Antibacterial Characteristics of Japanese Bamboo
Natural materials, such as bamboo, is able to withstand the rough conditions posed by its environment, such as resistance to degradation by microorganisms, due to notable antibacte...
Novel Benzoxazole Derivatives as Potential Acetylcholinesterase (AChE) Inhibitors in Alzheimer's Disease: Molecular Docking and Pharmacokinetics Analysis
Novel Benzoxazole Derivatives as Potential Acetylcholinesterase (AChE) Inhibitors in Alzheimer's Disease: Molecular Docking and Pharmacokinetics Analysis
ABSTRACT
Alzheimer's disease (AD) is a neurodegenerative disease whose leading cause is multiple brain abnormalities caused by the aging proc...
Recent Advances in Benzoxazole Derivatives: Pharmacological Potential and Therapeutic Applications
Recent Advances in Benzoxazole Derivatives: Pharmacological Potential and Therapeutic Applications
Abstract:
This review provides a focused analysis of recent developments in the design, synthesis,
and pharmacological evaluation of benzoxazole derivatives, em...
CDRxAbs: Antibody Small-Molecule Conjugates with Computationally Designed Target-Binding Synergy
CDRxAbs: Antibody Small-Molecule Conjugates with Computationally Designed Target-Binding Synergy
Abstract
Antibody-drug conjugates (ADCs) combine the advantages and offset the disadvantages of their constituent parts to achieve a refined spectrum of action. We ...

